Drugs that contain Mycophenolic Sodium
1. Myfortic patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6025391 | NOVARTIS | Enteric-coated pharmaceutical compositions of mycophenolate |
Apr, 2017
(7 years ago) | |
| US6172107 | NOVARTIS | Entric-coated pharmaceutical compositions |
Apr, 2017
(7 years ago) | |
| US6306900 | NOVARTIS | Enteric coated pharmaceutical compositions |
Feb, 2018
(6 years ago) | |
Market Authorisation Date: 27 February, 2004
Treatment: Prophylaxis of organ rejection in patients receiving allogeneic renal transplants
Dosage: TABLET, DELAYED RELEASE;ORAL
How can I launch a generic of MYFORTIC before it's drug patent expiration?
More Information on Dosage
MYFORTIC family patents
